PRACA ORYGINALNA
Median neuropathy at the wrist in patients with systemic sclerosis: two-year follow-up study
Więcej
Ukryj
Data nadesłania: 16-07-2018
Data ostatniej rewizji: 10-09-2018
Data akceptacji: 24-09-2018
Data publikacji online: 31-10-2018
Data publikacji: 31-10-2018
Reumatologia 2018;56(5):294-300
SŁOWA KLUCZOWE
DZIEDZINY
STRESZCZENIE
Objectives:
To determine the incidence and factors associated with median neuropathy at the wrist (MNW) in systemic sclerosis (SSc) patients using an electrodiagnostic (EDX) study.
Material and methods:
SSc patients who attended the scleroderma clinic, Srinagarind Hospital, were prospectively evaluated by questionnaire, physical examination, and EDX study. The questionnaire consisted of the baseline characteristics, type of scleroderma, clinical signs and symptoms associated with scleroderma, and the Boston questionnaire. The physical examinations were the Modified Rodnan Skin Score, motor power grading of bilateral abductor pollicis brevis muscle, and pinprick sensation of median nerve distribution of both hands. Moreover, the EDX study, which was composed of median and ulnar sensory and motor nerve conduction studies of both hands and electromyography of the abductor pollicis brevis muscles, was evaluated at baseline and following two years.
Results:
Out of 75 systemic sclerosis patients, 50 individuals participated in the study. Diffuse cutaneous type of SSc is the most common type (72%). The common SSc associated symptoms were Raynaud phenomenon, skin tightness and hand deformity. Incidence of MNW was 90 cases per 1000 person-years. Following a two-year interval, the percentages of mild, moderate and severe MNW were 28%, 22% and 6% respectively. Most of those with MNW were still particularly asymptomatic in a mild degree. Moreover, 12 out of 50 patients (24%) had a worse EDX result. There was no statistically significant association between MNW occurrence and studied factors.
Conclusions:
MNW commonly has high incidence in SSc patients. Therefore, SSc patients should be followed up in both clinical and EDX studies for MNW screening. SSc patients with asymptomatic MNW might need clinical follow-up for early diagnosis.
REFERENCJE (23)
1.
Chammas M, Boretto J, Burmann LM, et al. Carpal tunnel syndrome – Part I (anatomy, physiology, etiology and diagnosis). Rev Bras Ortop 2014; 49: 429-436.
2.
Werner RA, Andary M. Carpal tunnel syndrome: pathophysiology and clinical neurophysiology. Clin Neuro Physiol 2002; 113: 1373-1381.
3.
Wahab KW, Sanya EO, Adebayo PB, et al. Carpal Tunnel Syndrome and Other Entrapment Neuropathies. Oman Med J 2017; 32: 449-454.
4.
Pogorzelski R, Kulakowska A, Halicka D, et al. Neurological and emotional profile of carpal tunnel syndrome patients. Przegl Lek 2011; 68: 269-273.
5.
Katz JN, Lew RA, Bessette L, et al. Prevalence and predictors of long-term work disability due to carpal tunnel syndrome. Am J Ind Med 1998; 33: 543-550.
6.
Fett N. Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies. Clin Dermatol 2013; 31: 432-437.
7.
Yagci I, Kenis-Coskun O, Ozsoy T, et al. Increased stiffness of median nerve in systemic sclerosis. BMC Musculoskelet Disord 2017; 18: 1-5.
8.
Machet L, Vaillant L, Machet MC, et al. Carpal tunnel syndrome and systemic sclerosis. Dermatology (Basel) 1992; 185: 101-103.
9.
Amaral TN, Peres FA, Lapa AT, et al. Neurologic involvement in scleroderma: A systematic review. Semin Arthritis Rheum 2013; 43: 335-347.
10.
Mondelli M, Romano C, Della Porta PD, et al. Electrophysiological evidence of “nerve entrapment syndromes” and subclinical peripheral neuropathy in progressive systemic sclerosis (scleroderma). J Neurol 1995; 242: 185-194.
11.
Poncelet AN, Connolly MK. Peripheral neuropathy in scleroderma. Muscle Nerve 2003; 28: 330-335.
12.
Lee P, Bruni J, Sukenik S. Neurological manifestations in systemic sclerosis (scleroderma). J Rheumatol 1984; 11: 480-483.
13.
Nimitbancha T, Sirasaporn P, Wattanapan P, et al. The prevalence of median neuropathy at wrist in systemic sclerosis patients at Srinagarind Hospital. J Sci Soc 2015; 42: 180-184.
14.
Suchtelen M, Becker S, Gruber J, et al. Progression of Carpal Tunnel Syndrome According to Electrodiagnostic Testing in Nonoperatively Treated Patients. Arch Bone Jt Surg 2014; 2: 185-191.
15.
Upatham S, Kumnerddee W. Reliability of Thai version Boston questionnaire. J Med Assoc Thai 2008; 91: 1250-1256.
16.
Rao BH, Kutub M, Patil SD. Carpal tunnel syndrome: Assessment of correlation between clinical, neurophysiological and ultrasound characteristics. J Sci Soc 2012; 39: 124-129.
17.
American Association of Electrodiagnostic Medicine, American Academy of Neurology, and American Academy of Physical Medicine and Rehabilitation. Practice parameter for electrodiagnostic studies in carpal tunnel syndrome: summary statement. Muscle Nerve 2002; 25: 918-922.
18.
Mondelli M, Giannini F, Giacchi M. Carpal tunnel syndrome incidence in a general population. Neurology 2002; 58: 289-294.
19.
Lee K-H, Lee C-H, Lee B-G, et al. The incidence of carpal tunnel syndrome in patients with rheumatoid arthritis. Int J Rheum Dis 2015; 18: 52-57.
20.
Makepeace A, Davis WA, Bruce DG, et al. Incidence and determinants of carpal tunnel decompression surgery in type 2 diabetes: The Fremantle Diabetes Study. Diabetes Care 2008; 31: 498-500.
21.
Lori S, Matucci-Cerinic M, Casale R, et al. Peripheral nervous system involvement in systemic sclerosis: the median nerve as target structure. Clin Exp Rheumatol 1996; 14: 601-605.
22.
Kucharz EJ. Thyroid disorders in patients with progressive systemic sclerosis: A review. Clin Rheum 1993; 12: 159-161.
23.
Widuchowska M, Kotulska A, Kopeć-Mędrek M, et al. Carpal tunnel syndrome as the early symptom of rapidly progressive systemic sclerosis in men. Wiad Lek 2010; 63: 33.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.